That range frequently provides a good balance of stability, target specificity, and ability to cross cell membranes or bind to receptors
A total of 3,533 patients were randomized to once-weekly subcutaneous semaglutide 1.0 mg or placebo
In addition, other therapeutic arsenals, including DNA-alkylating agents, natural products, antimetabolites, hormone agonists/antagonists, and specific inhibitors, such as kinase inhibitors, monoclonal antibodies, or small organic molecules, are available and are used for cancer therapy (6,7)
These products have been in the human diet for centuries
With regular monitoring, lifestyle support, and open communication, patients and practitioners can manage most side effects effectively